BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 23-Jan-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2020 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2019.

PHARMAID 07-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

PHARMAID 06-Nov-2019

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2019. Date of AGM: 26.12.2019, Time: 11:00 AM, Venue: Kendrio Kanchi Kancher Mela Auditorium, 37/A Segun Bagicha, Dhaka-1000. Record date: 02.12.2019 The Company has also reported EPS of Tk. 15.48, NAV per share of Tk. 71.08 and NOCFPS of Tk. 8.05 for the year ended on June 30, 2019 as against Tk. 15.07, Tk. 60.81 and Tk. 12.51 respectively for the same period of the previous year.

PHARMAID 29-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 05, 2019 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

PHARMAID 24-Apr-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

PHARMAID 24-Jan-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2019 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2018.

PHARMAID 11-Nov-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

PHARMAID 06-Nov-2018

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2018. Date of AGM: 27.12.2018, Time: 11:00 AM, Venue: Kendrio Kanchi Kancher Mela Auditorium, 37/A Segun Bagicha, Dhaka-1000. Record date: 02.12.2018. The Company has also reported EPS of Tk. 15.07, NAV per share of Tk. 60.81 and NOCFPS of Tk. 12.51 for the year ended on June 30, 2018 as against Tk. 9.48, Tk. 49.53 and Tk. 4.09 respectively for the same period of the previous year.

PHARMAID 28-Oct-2018

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 05, 2018 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2018.

PHARMAID 24-Apr-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2018.

Previous Next page